Cited by 612Menopause: Health Impacts and TreatmentsHormonal and reproductive studiesEstrogen and related hormone effects

The DOI matches its Crossref record; 228 of the 230 references it cites were found in a registry or an index.

Hormone therapy for preventing cardiovascular disease in post-menopausal women

Open access

Boardman, Henry MP, Hartley, Louise, Eisinga, Anne, Main, Caroline, Roqué i Figuls, Marta, Bonfill Cosp, Xavier, Gabriel Sanchez, Rafael, Knight, Beatrice·2015·Cochrane Database of Systematic Reviews

DOI 10.1002/14651858.cd002229.pub4PMC PMC10183715

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Evidence from systematic reviews of observational studies suggests that hormone therapy may have beneficial effects in reducing the incidence of cardiovascular disease events in post-menopausal women, however the results of randomised controlled trials (RCTs) have had mixed results. This is an updated version of a Cochrane review published in 2013. OBJECTIVES: To assess the effects of hormone therapy for the prevention of cardiovascular disease in post-menopausal women, and whether there are differential effects between use in primary or secondary prevention. Secondary aims were to undertake exploratory analyses to (i) assess the impact of time since menopause that treatment was commenced (≥ 10 years versus < 10 years), and where these data were not available, use age of trial participants at baseline as a proxy (≥ 60 years of age versus < 60 years of age); and (ii) assess the effects of length of time on treatment. SEARCH METHODS: We searched the following databases on 25 February 2014: Cochrane Central Register of Controlled Trials (CENTRAL) in The Cochrane Library, MEDLINE, EMBASE and LILACS. We also searched research and trials registers, and conducted reference checking of relevant studies and related systematic reviews to identify additional studies. SELECTION CRITERIA: RCTs of women comparing orally administered hormone therapy with placebo or a no treatment control, with a minimum of six months follow-up. DATA COLLECTION AND ANALYSIS: Two authors independently assessed study quality and extracted data. We calculated risk ratios (RRs) with 95% confidence intervals (CIs) for each outcome. We combined results using random effects meta-analyses, and undertook further analyses to assess the effects of treatment as primary or secondary prevention, and whether treatment was commenced more than or less than 10 years after menopause. MAIN RESULTS: We identified six new trials through this update. Therefore the review includes 19 trials with a total of 40,410 post-menopausal women. On the whole, study quality was good and generally at low risk of bias; the findings are dominated by the three largest trials. We found high quality evidence that hormone therapy in both primary and secondary prevention conferred no protective effects for all-cause mortality, cardiovascular death, non-fatal myocardial infarction, angina, or revascularisation. However, there was an increased risk of stroke in those in the hormone therapy arm for combined primary and secondary prevention (RR 1.24, 95% CI 1.10 to 1.41). Venous thromboembolic events were increased (RR 1.92, 95% CI 1.36 to 2.69), as were pulmonary emboli (RR 1.81, 95% CI 1.32 to 2.48) on hormone therapy relative to placebo.The absolute risk increase for stroke was 6 per 1000 women (number needed to treat for an additional harmful outcome (NNTH) = 165; mean length of follow-up: 4.21 years (range: 2.0 to 7.1)); for venous thromboembolism 8 per 1000 women (NNTH = 118; mean length of follow-up: 5.95 years (range: 1.0 to 7.1)); and for pulmonary embolism 4 per 1000 (NNTH = 242; mean length of follow-up: 3.13 years (range: 1.0 to 7.1)).We performed subgroup analyses according to when treatment was started in relation to the menopause. Those who started hormone therapy less than 10 years after the menopause had lower mortality (RR 0.70, 95% CI 0.52 to 0.95, moderate quality evidence) and coronary heart disease (composite of death from cardiovascular causes and non-fatal myocardial infarction) (RR 0.52, 95% CI 0.29 to 0.96; moderate quality evidence), though they were still at increased risk of venous thromboembolism (RR 1.74, 95% CI 1.11 to 2.73, high quality evidence) compared to placebo or no treatment. There was no strong evidence of effect on risk of stroke in this group. In those who started treatment more than 10 years after the menopause there was high quality evidence that it had little effect on death or coronary heart disease between groups but there was an increased risk of stroke (RR 1.21, 95% CI 1.06 to 1.38, high quality evidence) and venous thromboembolism (RR 1.96, 95% CI 1.37 to 2.80, high quality evidence). AUTHORS' CONCLUSIONS: Our review findings provide strong evidence that treatment with hormone therapy in post-menopausal women overall, for either primary or secondary prevention of cardiovascular disease events has little if any benefit and causes an increase in the risk of stroke and venous thromboembolic events.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1002/14651858.cd002229.pub4

Cites

228 of 228 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

1 retracted

RETRACTED: Combined therapy with estrogen and etidronate has an additive effect on bone mineral density in the hip and vertebrae: Four-year randomized study
Wimalawansa, S. J. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80102-8 · Cited by 152
Retracted
The CES-D Scale: A Self-Report Depression Scale for Research in the General Population
Radloff, L. S. (1977) · Applied Psychological Measurement · doi:10.1177/014662167700100306 · Cited by 53,267
Untitled work
(1992) · PubMed · Cited by 33,716
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
EuroQol: a new facility for the measurement of health-related quality of life
(1990) · Health Policy · doi:10.1016/0168-8510(90)90421-9 · Cited by 15,736
Pharmacological interventions for somatoform disorders in adults
Kleinstäuber, M., Witthöft, M., Steffanowski, A., van Marwijk, H., Hiller, W., & Lambert, M. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010628.pub2 · Cited by 11,369
Global status report on noncommunicable diseases 2010.
Alwan, A. (2011) · Cited by 8,494
Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
Hulley, S. (1998) · JAMA · doi:10.1001/jama.280.7.605 · Cited by 6,216
Effects of Conjugated Equine Estrogen in Postmenopausal Women With Hysterectomy: The Women's Health Initiative Randomized Controlled Trial
(2004) · JAMA · doi:10.1001/jama.291.14.1701 · Cited by 4,534

Show all 230 references

Research works printed but not linked: 21

Hsia, 2006, Conjugated equine estrogens and coronary heart disease, Archives of Internal Medicine, 291, 1701
Grady, 2002, Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II), JAMA, 288, 49, 10.1001/jama.288.1.49 · DOI
Madsen, 2003, Positive impact of hormone replacement therapy on the fibrinolytic system: a long-term randomized controlled study in healthy postmenopausal women, Journal of Thrombosis and Haemostasis, 1, 1984, 10.1046/j.1538-7836.2003.00362.x · DOI
Pagliaro D Tangalakis K Kingwell B Craven R Carey M Stojanovska L The effects of hormone replacement therapy (HRT) on performance, cardiovascular parameters and bone resorption in post menopausal 'masters' athletes Proceedings of the 3rd Congress of the Australasian Menopause Society; 1999; Cairns 1999
Post, 2003, Route of HRT administration and risk factors for venous thrombosis: A randomized, placebo-controlled study in healthy postmenopausal women, International Journal of Obstetrics and Gynecology, 83, 35
Gallagher, 2012, Bazedoxifene/conjugated estrogens: Effects on bone mineral density and bone turnover markers in a double-blind, randomised, placebo- and active-controlled phase 3 study, Osteoporosis International, 23, S63
Mirkin, 2012, Effects of bazedoxifene/conjugated estrogens on coagulation parameters in a 1-year, randomized, placebo-and active-controlled, phase 3 trial of postmenopausal women, Endocrine Reviews, 33, 3 Meeting Abstr
Ylikorkala, 1999, Effects of a 1-year pulsed progestogen, constant estrogen hormone replacement therapy regimen, Prefest, on serum lipid levels in postmenopausal women, European Journal of Obstetrics, Gynecology, and Reproductive Biology, 86, S18
Naftolin, 2012, Adverse events during four years of daily oral conjugated estrogen or transdermal estradiol plus cyclic oral progesterone treatment in recently menopausal women: The KRONOS early estrogen prevention study (KEEPS), Menopause, 19, 1402
Howard, 2011, The early versus late intervention trial with estradiol (ELITE), Climacteric, 14, 35
Curb, 2006, Venous thrombosis and conjugated equine estrogen in women without a uterus, Archives of Internal Medicine, 166, 772, 10.1001/archinte.166.7.772 · DOI
Cushman, 2004, Estrogen plus progestin and risk of venous thrombosis, JAMA, 292, 1573, 10.1001/jama.292.13.1573 · DOI · Paper page
Maat, 2007, Genetic variation in estrogen receptor, C-reactive protein and fibrinogen does not predict the plasma levels of inflammation markers after long term hormone replacement therapy, Thrombosis and Haemostasis, 97, 234, 10.1160/TH06-08-0426 · DOI
Grady, 1998, Heart and Estrogen/progestin Replacement Study (HERS): design, methods, and baseline characteristics, Controlled Clinical Trials, 19, 314, 10.1016/S0197-2456(98)00010-5 · DOI · Paper page
Hendrix, 2006, Effects of conjugated equine estrogen on stroke in the women's health initiative, Circulation, 113, 2425, 10.1161/CIRCULATIONAHA.105.594077 · DOI
Hsia, 2006, Conjugated equine estrogens and coronary heart disease: The Women's Health Initiative, Archives of Internal Medicine, 166, 357, 10.1001/archinte.166.3.357 · DOI
Manson, 2003, Estrogen plus progestin and the risk of coronary heart disease, New England Journal of Medicine, 349, 523, 10.1056/NEJMoa030808 · DOI · Paper page
The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014
Stefanick, 2003, The Women's Health Initiative postmenopausal hormone trials: overview and baseline characteristics of participants, Annals of Epidemiology, 13, S78, 10.1016/S1047-2797(03)00045-0 · DOI
Tofteng, 2002, Two Polymorphisms in the Vitamin D Receptor Gene—Association With Bone Mass and 5-Year Change in BoneMass With or Without Hormone-Replacement Therapy inPostmenopausal Women: The Danish OsteoporosisPrevention Study, Journal of Bone and Mineral Research, 17, 1535, 10.1359/jbmr.2002.17.8.1535 · DOI
Wassertheil-Smoller, 2003, Effect of estrogen plus progestin on stroke in postmenopausal women, JAMA, 289, 2673, 10.1001/jama.289.20.2673 · DOI

Sorted by citations

Items 301–400 of 608

A mini-review of the evidence for cerebrovascular changes following gender-affirming hormone replacement therapy and a call for increased focus on cerebrovascular transgender health
Wright, M. E., & Murphy, K. (2023) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2023.1303871 · Cited by 6
Time trends in breast cancer and menopause hormone therapy use in New Zealand
Farmer, R. D. T., & Fenton, A. J. (2015) · Climacteric · doi:10.3109/13697137.2015.1098610 · Cited by 7
The influence of menopause on life of working women: the problem without necessary attention
Ilina, L. M., Yureneva, S. V., Dubrovina, A. V., & Ebzieva, Z. K. (2016) · Russian Journal of Human Reproduction · doi:10.17116/repro201622187-94 · Cited by 7
Estrogen Replacement Therapy Decreases Associated Risk of Postoperative Venous Thromboemboli and Medical Complications After Total Joint Arthroplasty
Zhao, S., Kelly, M., Smith, S. J., Heckmann, N. D., Schabel, K., Lieberman, E. G., Yoo, J. U., & Kagan, R. P. (2025) · The Journal of Arthroplasty · doi:10.1016/j.arth.2025.05.027 · Cited by 6
Step-by-step guide and checklists for selecting and conducting an evidence synthesis study using a framework for approaches and methods in evidence synthesis (FRAMES)
Dwivedi, A. K. (2026) · PeerJ · doi:10.7717/peerj.20897 · Cited by 6
Association between hormone therapy and short-term cardiovascular events in women with spontaneous coronary artery dissection
Mori, R., Macaya, F., Giacobbe, F., Moreno, V. H., Quadri, G., Chipayo, D., Bianco, M., Salinas, P., Rolfo, C., Mejía-Rentería, H. D., et al. (2022) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2022.07.004 · Cited by 6
The extract of Trachelospermum jasminoides (Lindl.) Lem. vines inhibits osteoclast differentiation through the NF-κB, MAPK and AKT signaling pathways
Jiang, T., Yan, W., Kong, B., Wu, C., Yang, K., Wang, T., Yan, X., Guo, L., Huang, P., Jiang, M., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110341 · Cited by 6
Estrogen and estrogen analogs for prevention and treatment of osteoporosis
Jiang, X., Randhawa, S. B., & Kagan, R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813073-5.00073-3 · Cited by 6
Fact or Fiction? The Role of Regulated Body-Identical Hormone Therapy for Menopausal Women
Donnelly, L., & Balneaves, L. G. (2022) · Nursing for Women s Health · doi:10.1016/j.nwh.2022.01.012 · Cited by 6
Effect of menopausal hormone therapy on methylation levels in early and late postmenopausal women
Hilser, J. R., Hartiala, J., Sriprasert, I., Kono, N., Cai, Z., Karim, R., DeYoung, J. A., Mack, W. J., Hodis, H. N., & Allayee, H. (2022) · Clinical Epigenetics · doi:10.1186/s13148-022-01311-w · Cited by 6
Long chain n-3 polyunsaturated fatty acid intake across the life span for cardiovascular disease prevention in women
Hall, W. L. (2024) · Proceedings of The Nutrition Society · doi:10.1017/s0029665124000181 · Cited by 7
The effect of hormone therapy on all-cause and cardiovascular mortality in women with chronic kidney disease: protocol for a systematic review and meta-analysis
Ramesh, S., Mann, M. C., Holroyd-Leduc, J. M., Wilton, S. B., James, M. T., Seely, E. W., & Ahmed, S. B. (2015) · Systematic Reviews · doi:10.1186/s13643-015-0020-8 · Cited by 6
Gender Differences in Associations Between Intraprocedural Thrombotic Events During Percutaneous Coronary Intervention and Adverse Outcomes
Schoos, M. M., Mehran, R., Dangas, G., Yu, J., Baber, U., Clemmensen, P. M., Feit, F., Gersh, B. J., Guagliumi, G., Ohman, E. M., et al. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.08.046 · Cited by 6
Actividades preventivas en la mujer. Actualización PAPPS 2018
García‐Franco, A. L., Fernández, J. A. B., Muñoz, E. B., Piñeiro, M. J. I., del Cura-González, I., del Moral, A. O., Goñi, J. L., Alonso‐Coello, P., & Mir, L. A. (2018) · Atención Primaria · doi:10.1016/s0212-6567(18)30366-4 · Cited by 6
Trials and tribulations of coronavirus disease-2019 research: with a few bright lights in the fog
Pasquale, G. D., Maggioni, A. P., Gervasoni, C., & Andreotti, F. (2020) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000001099 · Cited by 6
Bias in animal studies of estrogen effects on cardiovascular disease: A systematic review and meta‐analysis
Berntsen, C. F., Rootwelt, P., & Dahm, A. E. A. (2021) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12507 · Cited by 6
The effect of tibolone treatment on fasting blood sugar, insulin, insulin resistance and endothelial function in postmenopausal women: A meta-analysis of randomized controlled trials
Zhu, Y., Zhu, Y., Chen, Y., Yan, Q., Baradwan, S., Găman, M., & Zanghelini, F. (2021) · Experimental Gerontology · doi:10.1016/j.exger.2021.111586 · Cited by 6
Menopausal hormone therapy and risk of cardiovascular events in women with prediabetes or type 2 diabetes: A pooled analysis of 2917 postmenopausal women
Yoshida, Y., Chen, Z., Baudier, R. L., Krousel-Wood, M. A., Anderson, A. H., Fonseca, V. A., & Mauvais‐Jarvis, F. (2022) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2022.01.016 · Cited by 6
Incidence of Ischaemic Heart Disease in Men and Women With End-Stage Kidney Disease: A Cohort Study
O’Lone, E., Kelly, P. J., Masson, P., Kotwal, S. S., Gallagher, M., Cass, A., Craig, J. C., & Webster, A. C. (2020) · Heart Lung and Circulation · doi:10.1016/j.hlc.2020.03.002 · Cited by 6
Oral oestrogen reverses ovariectomy-induced morning surge hypertension in growth-restricted mice
Haskell, S. E., Peotta, V. A., Reinking, B. E., Zhang, C., Zhu, V. L., Kenkel, E. J., & Roghair, R. D. (2016) · Clinical Science · doi:10.1042/cs20150693 · Cited by 6
The Role of Menopausal Hormone Therapy in Reducing All-cause Mortality in Postmenopausal Women Younger than 60 Years: An Adaptive Meta-analysis
Bae, J., & Yoon, B.-K. (2018) · Journal of Menopausal Medicine · doi:10.6118/jmm.2018.24.3.139 · Cited by 6
Looking at HRT in perspective
Hamoda, H., & Moger, S. (2022) · BMJ · doi:10.1136/bmj.o1425 · Cited by 6
Criteria for the choice and monitoring of Menopausal Hormone Therapy
Ruan, X., & Mueck, A. O. (2024) · Current Medicine · doi:10.1007/s44194-024-00038-5 · Cited by 6
High glucose induces hippocampal neuron impairment through the SKP1/COX7C pathway: A potential mechanism for perimenopausal depression
Wang, Z., Liu, Z., Feng, S., Song, X., Liu, D., Ma, N., Zhang, X., Liu, W., Wang, D. O., Liu, X., et al. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.09.003 · Cited by 7
Assessing and Modifying Coronary Artery Disease Risk in Women
Sarma, A. A., & Scott, N. S. (2017) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-017-0554-2 · Cited by 5
The Effects of Menopausal Hormone Therapy on Serum Level of C-reactive Protein in Postmenopausal Korean Women
Shin, W., Kim, S. E., Lee, J.-Y., Seo, J.-W., Hyun, H. S., Suh, J. H., Choi, D., & Yoon, B.-K. (2019) · Journal of Menopausal Medicine · doi:10.6118/jmm.2019.25.1.49 · Cited by 5
Addendum to: Peri- and postmenopause—diagnosis and interventions interdisciplinary S3 guideline of the association of the scientific medical societies in Germany (AWMF 015/062): short version
for the Guideline Group, Ortmann, O., Beckermann, M. J., Inwald, E. C., Strowitzki, T., Windler, E. E. T., & Tempfer, C. M. (2021) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-021-06009-7 · Cited by 5
The menopause: symptoms, treatments and implications for women’s health and well-being
Holloway, D. (2022) · Primary Health Care · doi:10.7748/phc.2022.e1759 · Cited by 5
Cardiometabolic Risk Factors and Endogenous Sex Hormones in Postmenopausal Women: A Cross-Sectional Study
Ottarsdottir, K., Tivesten, Å., Li, Y., Lindblad, U., Hellgren, M. I., Ohlsson, C., & Daka, B. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac050 · Cited by 5
Menopausal Hormone Therapy and Subclinical Cardiovascular Disease in Women With and Without Human Immunodeficiency Virus
Peters, B. A., Hanna, D. B., Sharma, A., Anastos, K., Hoover, D. R., Shi, Q., Moran, C. A., Jackson, E. A., Alcaide, M. L., Ofotokun, I., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac620 · Cited by 5
Real‐world practice of estrogen and progestogen prescriptions in menopausal women in Japan: A descriptive study using a Japanese claims database
Inayama, Y., Mizuno, K., Egawa, M., Yamaguchi, K. D., Hamanishi, J., Takeuchi, M., Mandai, M., & Kawakami, K. (2023) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.15795 · Cited by 5
Acute Coronary Syndromes in Women: A Narrative Review of Sex-Specific Characteristics
Theofilis, P., Vlachakis, P. K., Mantzouranis, E., Sakalidis, A., Chrysohoou, C. A., Leontsinis, I., Lazaros, G. A., Dimitriadis, K. S., Drakopoulou, M. I., Vordoni, A., et al. (2023) · Angiology · doi:10.1177/00033197231218331 · Cited by 5
Primary Prevention of Coronary and Other Cardiovascular Diseases: A Focused Review
Higashiyama, A., Kohsaka, S., & Fujiyoshi, A. (2024) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.rv22019 · Cited by 6
Age-related trends of ischemic sudden cardiac death in women
Hookana, I., Eskuri, M. A. E., Holmström, L., Vähätalo, J., Kenttä, T. V., Tikkanen, J. T., Pakanen, L., Perkiömäki, J. S., Huikuri, H., & Junttila, J. M. (2024) · International Journal of Cardiology · doi:10.1016/j.ijcard.2024.132238 · Cited by 5
Update on Ischemic Heart Disease and Critical Care Cardiology
Marín, F. R., Dı́az-Castro, Ó., Ruiz-Nodar, J. M., de la Villa, B. G., Sionís, A., López, J., Fernández‐Ortíz, A., & Martínez‐Sellés, M. (2014) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2013.11.001 · Cited by 5
A call to increase the use of hormone therapy to prevent disease in symptomatic postmenopausal women
Sarrel, P. M. (2019) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001324 · Cited by 5
Management of menopause: modern trends
Татарчук, Т. Ф. (2019) · Reproductive Endocrinology · doi:10.18370/2309-4117.2019.46.19-37 · Cited by 5
Effects of 17β-Estradiol on the Plasminogen Activator System in Vascular Smooth Muscle Cells Treated with Lysophophatidylcholine
Yoon, B.-K., Kang, Y.-H., Oh, W., Lee, D., Kim, D., Kessel, B., & Kang, C.-D. (2020) · Journal of Menopausal Medicine · doi:10.6118/jmm.19005 · Cited by 5
Beyond hot flashes: Exploring the role of estrogen therapy in postmenopausal women for myocardial infarction prevention and recovery
Choradia, A., Bai, K., Soni, S., Nguyen, N. M. T., Adhikari, S., Rahul, D. K., & Gupta, R. K. (2023) · Biomolecules and Biomedicine · doi:10.17305/bb.2023.9535 · Cited by 5
HTA et traitement hormonal de la menopause
Mounier‐Véhier, C., Bejan‐Angoulvant, T., Boivin, J., & Plu‐Bureau, G. (2019) · La Presse Médicale · doi:10.1016/j.lpm.2019.09.027 · Cited by 5
Long-term menopausal hormone therapy and health consequences – how to choose sides?
Pines, A., & Shapiro, S. (2015) · Climacteric · doi:10.3109/13697137.2015.1041756 · Cited by 5
Changing the conversation about hormone therapy
Pinkerton, J. V. (2017) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000965 · Cited by 5
Cardiovascular risk after withdrawal of hormone therapy
Hodis, H. N., & Mack, W. J. (2018) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001076 · Cited by 5
A review of menopause in transgender and gender diverse individuals
Kelley, C. E., & Ariel, D. (2025) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000001013 · Cited by 4
Long-term hormone therapy for perimenopausal and postmenopausal women
Rodriguez, M. B., Yong, L. N., Mirkov, S., Bekos, C., Lethaby, A. E., & Farquhar, C. M. (2026) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004143.pub7 · Cited by 5
Breast and endometrial safety of micronised progesterone versus norethisterone acetate in menopausal hormone therapy (PROBES): study protocol of a double-blind randomised controlled trial
Lundell, C., Στεργιόπουλος, Ν., Blomberg, L., Ujvári, D., Schuppe‐Koistinen, I., Kallner, H. K., Iliadis, S. I., Skalkidou, A., & Hirschberg, A. L. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-082749 · Cited by 4
Actividades preventivas en la mujer. Actualización PAPPS 2024
García‐Franco, A. L., Alonso‐Coello, P., Iglesias, A. P., Fernádez, C. G., Pineda, E. R., & Goñi, J. L. (2024) · Atención Primaria · doi:10.1016/j.aprim.2024.103131 · Cited by 4
Cross-sectional and Longitudinal Relationship Between Sex Hormones and 6 Epigenetic Clocks in Older Adults: Results of the Berlin Aging Study II
Schmid, H., Vetter, V. M., Homann, J., Bahr, V., Lill, C. M., Regitz‐Zagrosek, V., Bertram, L., & Demuth, I. (2025) · The Journals of Gerontology Series A · doi:10.1093/gerona/glaf106 · Cited by 4
The impact of omentin-1 gene polymorphisms (rs2274907 and rs2274908) on serum lipid concentrations and coronary artery disease in a sample of Iraqi individuals (A pilot study)
Al-Barqaawi, M. A., Al-Kashwan, T. A. J., Mahdi, A. G., Mirza, T. J., Amber, K. I., & Hussain, M. K. (2021) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2021.11.005 · Cited by 5
Primary Prevention of Cardiovascular Disease in Women
Shahid, I., Avenatti, E., Titus, A., Al-Kindi, S. G., & Nasir, K. (2024) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcvj.1313 · Cited by 7
Diretriz Brasileira sobre a Saúde Cardiovascular no Climatério e na Menopausa – 2024
de Oliveira, G. M. M., de Almeida, M. C. C., Artucio, C., Espíndola, L. N., Rivera, M. A. M., Filho, A. L. D. S., Marques-Santos, C., Fernandes, C. E., Albuquerque, C. J. D. M., Freire, C. M. V., et al. (2024) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20240478 · Cited by 24
Menopausal Hormone Therapy: Its Role in the Prevention of Cardiovascular Diseases and the Risk of Breast Cancer in Women
Tran, T. T. T., Phung, T. M., Do, A. T. M., Ly, Q. T. M., & Nguyen, T. H. (2025) · Clinical and Experimental Obstetrics & Gynecology · doi:10.31083/ceog26813 · Cited by 4
Primary and secondary cardiovascular prevention through life cycles in women. Consensus document of the SEC-GT CVD in Women, ACP-SEC, SEGO, AEEM, SEEN, semFYC, SEMERGEN, AEP, and AEM
Sambola, A., Campuzano, R., Castro, A., Goya, M., Coronado, P., Fernández-Olmo, R., Tablado, M. Á. M., Ortiz-Cortés, C., Ortolà, X., Pallarés‐Carratalá, V., et al. (2025) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2025.01.005 · Cited by 7
Traitement hormonal de ménopause et risque cardiovasculaire. RPC Les femmes ménopausées du CNGOF et du GEMVi
Plu‐Bureau, G., & Mounier‐Véhier, C. (2021) · Gynécologie Obstétrique Fertilité & Sénologie · doi:10.1016/j.gofs.2021.03.017 · Cited by 6
Le traitement hormonal de la ménopause en pratique. RPC Les femmes ménopausées du CNGOF et du GEMVi
Gosset, A., Robin, G., Letombe, B., Pouillès, J. M., & Trémollières, F. (2021) · Gynécologie Obstétrique Fertilité & Sénologie · doi:10.1016/j.gofs.2021.03.019 · Cited by 4
Don't be so quick to stop hormone-replacement therapy
Løbo, R. A. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.195 · Cited by 4
Menopausia y Terapia Hormonal de la Menopausia Las recomendaciones 2018 de la Unidad de Endocrinología Ginecológica de Clínica Alemana de Santiago -Sociedad Italiana de la Menopausia y la Sociedad Chilena de Endocrinología Ginecológica
Parra, M., LAGOS, N., Marco Levancini, A., Villarroel, M., Pizarro, E., Vanhauwaert, P. S., Velasco, S., Fernadez, M., Gambacciani, M., Biglia, N., et al. (2018) · Revista chilena de obstetricia y ginecología · doi:10.4067/s0717-75262018000500527 · Cited by 4
Risk of cardiovascular disease after preventive salpingo-oophorectomy
Johansen, N., Tonstad, S., Liavaag, A. H., Selmer, R. M., Tanbo, T. G., & Michelsen, T. M. (2020) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-2019-000856 · Cited by 4
Methodological education in response to the quality of COVID-19 publications
Andreotti, F., Gervasoni, C., Pasquale, G. D., & Maggioni, A. P. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105381 · Cited by 4
Women’s Heart Programs
Aggarwal, N. R., & Mulvagh, S. L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819369-3.00002-2 · Cited by 4
Dyslipidemia in Women: Etiology and Management
Rajai, N., & Welty, F. K. (2021) · Stroke revisited · doi:10.1007/978-981-16-3923-4_16 · Cited by 6
Concurrent use of Chinese herbal medicine among hormone users and its association with ischemic stroke risk: A population-based study
Wen, S., Chang, W., Hong, M.-K., & Wu, H.-C. (2018) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2018.01.020 · Cited by 4
Østrogener i menopausen – på tide å endre anbefalingene?
Eriksen, E. F., Moen, M. H., & Iversen, O. E. (2018) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.17.1059 · Cited by 4
Managing common problems in the menopause
Newson, L. R., & Panay, N. (2018) · InnovAiT Education and inspiration for general practice · doi:10.1177/1755738018769925 · Cited by 4
A review of menopausal hormone therapy: recalibrating the balance of benefit and risk
Rajan, S., & Kreatsoulas, C. (2019) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.4412 · Cited by 4
Changing the conversation about hormone therapy
Pinkerton, J. V. (2017) · Climacteric · doi:10.1080/13697137.2017.1346380 · Cited by 4
Measures of association in clinical trials: definition and interpretation.
Carneiro, A. V. (2003) · PubMed · Cited by 4
Female Adipose Tissue Sex Steroid Biosynthesis
Hetemäki, N., Mikkola, T. S., & Savolainen-Peltonen, H. M. (2025) · Seminars in Reproductive Medicine · doi:10.1055/s-0045-1811952 · Cited by 5
Russian eligibility criteria for prescription of menopausal hormone therapy to patients with cardiovascular and metabolic diseases. Agreement document of RKO, ROAG, RAE, EAT, AFR, RNMOT, RAGG
Shlyakhto, E. V., Dedov, I. I., Serov, V. N., Sukhikh, G. T., Arutyunov, G. P., Suchkov, I. A., Drapkina, O. M., Tkacheva, O. N., Orlova, Y. A., Baranov, I. A., et al. (2026) · Problems of Endocrinology · doi:10.14341/probl13694 · Cited by 3
Women’s midlife: the front line of Alzheimer prevention
Mosconi, L. (2026) · Journal of Clinical Investigation · doi:10.1172/jci199832 · Cited by 9
Posicionamiento AEEM-SEGO sobre la terapia hormonal de la menopausia
Sánchez‐Borrego, R., Coto, P. L., de Guevara, N. M. L., Delgado, R. C., Barriendos, J. F., Baquedano, L., Jurado, A. R., Manubens, M., García-Ramos, B. O., López, D. M. L., et al. (2019) · Progresos de Obstetricia y Ginecología · doi:10.20960/j.pog.00094 · Cited by 3
Postmenopausal hormone therapy in prior pre-eclamptic women: a nationwide cohort study in Finland
Venetkoski, M., Ylikorkala, O., Joensuu, J., Gissler, M., Mikkola, T. S., & Savolainen-Peltonen, H. M. (2023) · Climacteric · doi:10.1080/13697137.2023.2228687 · Cited by 3
Summary of the 2023 Thai Menopause Society Clinical Practice Guideline on Menopausal Hormone Therapy
Chaikittisilpa, S., Orprayoon, N., Vallibhakara, O., Vallibhakara, S. A.-O., Tanmahasamut, P., Somboonporn, W., Rattanachaiyanont, M., Techatraisak, K., & Jaisamrarn, U. (2024) · Journal of Menopausal Medicine · doi:10.6118/jmm.24006 · Cited by 3
Hormone replacement therapy and myocardial infarction and stroke in postmenopausal Korean women
Baek, J. K., Kim, H., Kang, M. J., Choi, E. A., Lee, J. K., Kim, E. H., & Seo, S. K. (2024) · Climacteric · doi:10.1080/13697137.2024.2354728 · Cited by 3
Brazilian Guideline on Menopausal Cardiovascular Health – 2024
de Oliveira, G. M. M., de Almeida, M. C. C., Artucio, C., Espíndola, L. N., Rivera, M. A. M., Filho, A. L. D. S., Marques-Santos, C., Fernandes, C. E., Albuquerque, C. J. D. M., Freire, C. M. V., et al. (2024) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.61622/rbgo/2024rbgo100 · Cited by 7
Female Reproductive Period Length, Parity and Hormonal Replacement Therapy and Dementia: The Elsi‐Brazil Study
Barbosa, M. G., Keinert, A. Á. M., Miguel, A. C., de Macêdo, M. A. C. F., Teixeira, L. M., Bertola, L., Lima‐Costa, M. F., & Ferri, C. P. (2024) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.70023 · Cited by 3
Hormone therapy and venous thromboembolism risk in women of menopausal age: a target trial emulation
Yeh, Y.-C., Yin, C., Chang, C. Y., & Chen, P. (2024) · European Journal of Epidemiology · doi:10.1007/s10654-024-01181-x · Cited by 4
The effects of transdermal estrogens combined with Medroxyprogesterone Acetate on cardiovascular disease risk factors in postmenopausal women: a meta-analysis of randomized controlled trials
Zhou, F., Prabahar, K., & Shu, J. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01664-1 · Cited by 3
Review of venous thromboembolism (VTE) risk, evaluation, and treatment in individuals on estrogen-based gender-affirming hormone therapy
Schachter, H., Blaszczak, J., & Barnes, G. D. (2025) · Vascular Medicine · doi:10.1177/1358863x251334141 · Cited by 4
Circulating Levels of Angiotensinogen, Sex Hormones, and Hormone Therapy—The Multi‐Ethnic Study of Atherosclerosis (MESA)
Lidani, K. C. F., Trainor, P. J., Buscaglia, R., Foster, K., Jaramillo, S., Michael, K. G. F. T., Landry, A. P., Michos, E. D., Ouyang, P., Morgan, E. S., et al. (2025) · Journal of Clinical Hypertension · doi:10.1111/jch.70083 · Cited by 3
Gender-based differences among ST-elevation myocardial infarction patients in Egypt: secondary analysis from the ACCA-EAPCI ESC-STEMI registry
Shaheen, S. M., Wafa, A. A., Mokarrab, M., Zarif, B., Bendary, A., Ahmed, T. A.-H. N., Rashwan, A., Seleem, M., Elmasry, M. M., Abdelhady, Y. A., et al. (2025) · The Egyptian Heart Journal · doi:10.1186/s43044-025-00671-x · Cited by 3
Trying times: domestication of healthcare technologies amidst challenging dynamic contexts
Fox, S. (2019) · Social Theory & Health · doi:10.1057/s41285-019-00107-y · Cited by 4
HRT for the Primary Prevention of Coronary Heart Disease
Stevenson, J. C. (2019) · ISGE series · doi:10.1007/978-3-030-11355-1_17 · Cited by 3
Actividades preventivas en la mujer. Actualización PAPPS 2020
García‐Franco, A. L., Fernández, J. A. B., Muñoz, E. B., Piñeiro, M. J. I., del Moral, A. O., Alonso‐Coello, P., Cabello, C. R., Goñi, J. L., & Mir, L. A. (2020) · Atención Primaria · doi:10.1016/j.aprim.2020.09.001 · Cited by 3
Understanding the importance of recognising, treating and preventing stroke
Chauhdry, H. (2021) · Nursing Standard · doi:10.7748/ns.2021.e11596 · Cited by 3
Russian Eligibility Criteria for Prescribing Menopausal Hormone Therapy to Patients With Cardiovascular and Metabolic Diseases. Consensus Document of RSC, RSOG, RAE, EUAT, RAP
Shlyakhto, E. V., Sukhikh, G. T., Serov, V. N., Dedov, I. I., Arutyunov, G. P., Suchkov, I. A., Orlova, Y. A., Andreeva, E. N., Yureneva, S. V., Yavelov, I. S., et al. (2023) · Kardiologiia · doi:10.18087/cardio.2023.10.n2561 · Cited by 4
Management of menopause for women with cardiovascular disease
Scottish Government Women’s Health and Heart Health Policy Teams with thanks to the numerous clinicians who helped and in collaboration with the medical advisory council of the British Menopause Society (2024) · Post Reproductive Health · doi:10.1177/20533691241302040 · Cited by 3
Probiotic Kefir Improves Renal Disorders in Ovariectomized Female SHR with High Fructose Intake–Induced Metabolic Syndrome
Escouto, L. D. S., Batista, T. J., Peixoto, P., Firmino, F. T., Ronchi, S. N., Barroso, M. E. D. S., Kampke, E. H., de Andrade, T. U., de Melo, A. F., & Bissoli, N. S. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10490-w · Cited by 3
Performance Enhancing Supplements and Cardiovascular Health
Singh, M., Givens, M., Singh, T. K., & Rao, P. (2025) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-025-01086-2 · Cited by 5
Systemic Estrogen Use and Discontinuation After Alzheimer’s Disease Diagnosis in Finland 2005–2012: A Nationwide Exposure-Matched Cohort Study
Tolppanen, A., Tiihonen, M., Taipale, H. T., Koponen, M., Tanskanen, A. J., Lavikainen, P., Tiihonen, J., & Hartikainen, S. A. (2018) · Drugs & Aging · doi:10.1007/s40266-018-0591-x · Cited by 3
Revisión narrativa de la evidencia actual acerca de las alternativas hormonales y no hormonales en el manejo de los síntomas vasomotores y urogenitales de la menopausia
Balcázar, D. S., & Badoui, N. (2018) · Universitas Médica · doi:10.11144/javeriana.umed60-1.meno · Cited by 3
Impact of radiotherapy on cardiovascular health of women with breast cancer
Lawrenson, R. A., Lao, C., Ali, A., & Campbell, I. (2018) · Journal of Medical Imaging and Radiation Oncology · doi:10.1111/1754-9485.12838 · Cited by 3
A Survey of Menopause Care Among US Women
Truong, S. R. (2019) · Journal of Gynecology and Obstetrics · doi:10.11648/j.jgo.20190702.11 · Cited by 3
Herbal Medicines (Danggui Liuhuang Decoctions) for Management of Menopausal Symptoms: A Systematic Review of Randomized Controlled Trials
Jun, J. H., Lee, H. W., Zhang, J., Yang, F., & Lee, M. S. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061778 · Cited by 3
Menopause
Hudson, T., & Katzinger, J. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-43044-9.00196-5 · Cited by 3
Uso de Terapia de Reposição Hormonal para Prevenção de Doenças Cardiovasculares na Pós-menopausa: Uma Revisão Sistemática / Use of Hormone Replacement Therapy to Prevent Postmenopausal Cardiovascular Diseases: A Systematic Review
Martins, M. V. F., Rosa, G. A., Negreiros, A. F., & Soares, G. C. (2021) · Brazilian Journal of Development · doi:10.34117/bjdv7n6-690 · Cited by 3
Primary and Secondary Prevention of Ischemic Heart Disease in Women
Kohli, P. (2015) · Current Atherosclerosis Reports · doi:10.1007/s11883-015-0518-5 · Cited by 3
Sex Hormones and Substrate Metabolism During Endurance Exercise
Isacco, L., & Boisseau, N. (2023) · Springer eBooks · doi:10.1007/978-3-031-21881-1_2 · Cited by 3
“BIVARIATE DISTRIBUTION” FOR INFRASTRUCTURES AMONG OPERATIVE, NATURAL AND NO MENOPAUSES
Shanmugam, R. (2014) · Current Research in Biostatistics · doi:10.3844/amjbsp.2014.34.44 · Cited by 3
Hormone therapy and cardiovascular disease – are we back to the beginning?
Fenton, A. J., & Panay, N. (2015) · Climacteric · doi:10.3109/13697137.2015.1057958 · Cited by 3

Authors: Boardman, H. M., Hartley, L., Eisinga, A., Main, C., Roqué i Figuls, M., Bonfill Cosp, X., Gabriel Sanchez, R., & Knight, B.
Affiliations: John Radcliffe Hospital (GB)
University of Warwick (GB)
National Institute for Health and Care Research (GB)
Cancer Research UK Clinical Trials Unit (GB)
CIBER Epidemiología y Salud Pública (CIBERESP); Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau); Sant Antoni Maria Claret 171 Edifici Casa de Convalescència Barcelona Catalunya Spain 08041
CIBER Epidemiología y Salud Pública (CIBERESP) - Universitat Autònoma de Barcelona; Iberoamerican Cochrane Centre - Biomedical Research Institute Sant Pau (IIB Sant Pau); Sant Antoni Maria Claret, 167 Pavilion 18 (D-13) Barcelona Catalunya Spain 08025
Hospital Universitario de la Paz, Universidad Autónoma de Madrid; Instituto de Investigacion IdiPAZ, Red Espanola de Investigacion Cardiovascular RD/12/0042/0008; Diego De Leon 62 Planta 9 Madrid Spain 28006
University of Exeter (GB)
ORCID: Boardman, Henry MP
Hartley, Louise
Main, Caroline
Venue: Cochrane Database of Systematic Reviews
Publisher: Wiley
Published: 2015-03-10
Volume: 2015
Issue: 8
Pages: CD002229-CD002229
ISSN: 1361-6137 (ISSN-L)
1465-1858
DOI: 10.1002/14651858.cd002229.pub4
PMC: PMC10183715
OpenAlex: W1927817986
Cited by: 612
References: 230
Citations by year: 2026: 35 · 2025: 57 · 2024: 69 · 2023: 64 · 2022: 42 · 2021: 63 · 2020: 46 · 2019: 60 · 2018: 48 · 2017: 50 · 2016: 32 · 2015: 26
FWCI: 7.83
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Cochrane Database of Systematic Reviews (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
Keywords: hormone therapy, postmenopausal women, cardiovascular disease prevention, primary prevention, secondary prevention, stroke risk, venous thromboembolism, myocardial infarction, all-cause mortality, cardiovascular mortality, time since menopause, treatment duration, oral hormone therapy, menopause, cardiovascular risk factors, cardiovascular risk reduction
MeSH terms: Adult, Aged, Aged, 80 and over, Cardiovascular Diseases, Cause of Death, Female, Humans, Middle Aged, Primary Prevention, Estrogen Replacement Therapy, Postmenopause, Hormone Replacement Therapy, Stroke, Venous Thromboembolism, Secondary Prevention

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Hormone therapy for preventing cardiovascular disease in post-menopausal women

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks